Rechte & Gesellschaft
EMA Introduces New PRIME Tools for Medicines
The European Medicines Agency (EMA) has launched three new features within its PRIME scheme. PRIME aims to enhance support for developing medicines that address unmet medical needs. The new tools are designed to accelerate the evaluation and approval process of these crucial medications. This initiative seeks to improve patient access to innovative treatments within the EU.
EMA enhances PRIME scheme to speed up development of medicines for unmet needs